cyclopentane has been researched along with Cancer of the Urinary Tract in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HC; Chang, SC; Chou, CT; Ho, IL; Hsieh, JT; Hsu, CH; Huang, KH; Kuo, KL; Lin, WC; Pu, YS; Shi, CS; Tsai, YC; Wu, JT | 1 |
1 other study(ies) available for cyclopentane and Cancer of the Urinary Tract
Article | Year |
---|---|
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies.
Topics: Animals; Apoptosis; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclopentanes; Flow Cytometry; Humans; Mice; NEDD8 Protein; Pyrimidines; Ubiquitin-Activating Enzymes; Ubiquitins; Urologic Neoplasms; Xenograft Model Antitumor Assays | 2015 |